Valneva SE (VALN) Tax Provisions (2021 - 2026)
Valneva SE's (VALN) quarterly Tax Provisions came in at -$964694.4 in Q1 2026, up 37.78% year-on-year from -$700165.9 in Q1 2025, and up 17.13% quarter-over-quarter from -$1.2 million in Q4 2025.
Valneva SE (VALN) Tax Provisions (2021 - 2026) Analysis & Trends
Valneva SE has disclosed Tax Provisions across 6 years of filings, most recently posting -$964694.4 for Q1 2026.
- Tax Provisions for Q1 2026 came in at -$964694.4, up 37.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.0 million (up 353.28% YoY), and the FY2025 annual result was $1.3 million, up 49.78% from the prior year.
- Tax Provisions came in at -$964694.4 for Q1 2026 at Valneva SE, up from -$1.2 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $5.0 million in Q4 2024 to a low of -$4.5 million in Q3 2024.
- The 5-year median for Tax Provisions is $108893.6 (2022), against an average of $150008.2.
- Across the five-year window, Tax Provisions surged 311.02% in 2023 and sank 17740.25% in 2025, its largest moves.
- Valneva SE's Tax Provisions stood at $639695.1 in 2022, then jumped by 185.43% to $1.8 million in 2023, then jumped by 175.07% to $5.0 million in 2024, then plunged by 123.18% to -$1.2 million in 2025, then increased by 17.13% to -$964694.4 in 2026.
- The last three Tax Provisions figures came in at -$964694.4 (Q1 2026), -$1.2 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Valneva SE | 163.67 Mn | 40.43 Mn | 5.08 Mn | -964,694.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -964,694.42 |
| Dec 31, 2025 | -1.16 Mn |
| Sep 30, 2025 | 3.92 Mn |
| Jun 30, 2025 | 252,427.01 |
| Mar 31, 2025 | -1.55 Mn |
| Dec 31, 2024 | 5.02 Mn |
| Sep 30, 2024 | -4.46 Mn |
| Jun 30, 2024 | 178,763.34 |
| Mar 31, 2024 | -8,690.89 |
| Dec 31, 2023 | 1.83 Mn |
| Sep 30, 2023 | -2.91 Mn |
| Jun 30, 2023 | 3.98 Mn |
| Mar 31, 2023 | 128,801.02 |
| Dec 31, 2022 | 639,695.10 |
| Sep 30, 2022 | 108,893.63 |
| Jun 30, 2022 | -1.89 Mn |
| Mar 31, 2022 | -563,413.53 |
| Dec 31, 2021 | 5.83 Mn |
| Sep 30, 2021 | -1.15 Mn |
| Jun 30, 2021 | -1.25 Mn |